Inovio Pharmaceuticals Inc vs Mattel Inc — how do they compare? Inovio Pharmaceuticals Inc trades at $1.08 (market cap $89.27M), while Mattel Inc trades at $14.19 (market cap $4.11B). The key difference: Mattel Inc is far larger — about 46× Inovio Pharmaceuticals Inc's market cap, and Mattel Inc is trading nearer its 52-week high, Inovio Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| INO | MAT | |
|---|---|---|
Market Cap | $89.27M | $4.11B |
Sector | Health | Consumer Cyclical |
52-Week High | $2.87 | $22.16 |
52-Week Low | $1.05 | $13.05 |
Enterprise Value | $60.28M | $5.92B |
Trailing returns across standard periods
Latest headlines on both assets
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →Mattel markets toy products that are sold to its wholesale customers and direct to retail consumers. The company offers products for children and families, including toys for infants and preschoolers, girls and boys, youth electronics, handheld and other games, puzzles, educational toys, media-driven products, and plush and fashion-related toys. Mattel's owned portfolio includes Barbie, Hot Wheels, Fisher-Price, Thomas & Friends, and American Girl. In addition, it currently manufactures toy products for its segments both internally and externally (through manufacturing partners). Just over half of its net sales are in North America, while the remainder stem from international markets.
Read more on MAT →